Osteocalcin: a new phenomenon for type 2 diabetes and obesity

HIGHLIGHTS

  • who: Kocak & Acar Tek from the Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi University, Ankara, TURKEY have published the paper: Osteocalcin: A new phenomenon for type 2 diabetes and obesity, in the Journal: (JOURNAL)

SUMMARY

    This review examines the role of OCN produced by osteoblasts in energy metabolism by affecting insulin, glucose metabolism, adipose_tissue, skeletal and muscle tissue, and appetite metabolism in understanding the endocrine functions of bone. Epidemiological studies to analyze the relationship between OCN and metabolic parameters such as glycemia, insulin secretion, cell proliferation, and lipid profile revealed . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?